Status:
UNKNOWN
Persistent Pulmonary Artery Hypertension After Valve Replacement
Lead Sponsor:
University Hospital, Bonn
Collaborating Sponsors:
Actelion Pharmaceuticals Deutschland GmbH
Conditions:
Persistent Severe PH After Valve Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Background: Persistent severe pulmonary hypertension (PH) after mechanical valve replacement is a frequent finding in patients with severe valve-diseases. The reasons to develop PH are multifactorial ...
Eligibility Criteria
Inclusion
- Proven pulmonary hypertension before valve replacement and informed consent for data acquisition
Exclusion
- patients do not meet inclusion criteria
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01238731
Start Date
January 1 2011
End Date
March 1 2012
Last Update
November 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Klinik II, University of Bonn
Bonn, Germany, 53125